Macquarie upgrades its forecasts, based on GNC's update. Now forecasting:
FY2022
Revenue: $6.02b
EBITDA: $519m
NPAT: $268m ($1.19/share)
Dividend: 27cps
FY2023
Revenue: $4.75b
EBITDA: $295m
NPAT: $117m (53c/share)
Dividend: 26cps
Its valuation and 12-month target price is $9.48.
I think Macquarie's dividend forecasts are light given expected npat, but they might be expecting ongoing share buybacks (remember that a $50m buy back is to commence this month ...).
- Forums
- ASX - By Stock
- GNC
- Ann: FY22 Earnings Guidance
GNC
graincorp limited
Add to My Watchlist
1.14%
!
$7.82

Ann: FY22 Earnings Guidance, page-20
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$7.82 |
Change
-0.090(1.14%) |
Mkt cap ! $1.736B |
Open | High | Low | Value | Volume |
$7.97 | $7.99 | $7.78 | $4.806M | 613.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 11967 | $8.37 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.04 | 3617 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 10014 | 7.780 |
12 | 21802 | 7.770 |
6 | 13233 | 7.760 |
4 | 17938 | 7.750 |
3 | 18437 | 7.740 |
Price($) | Vol. | No. |
---|---|---|
7.820 | 75 | 1 |
7.830 | 6620 | 3 |
7.840 | 8235 | 4 |
7.850 | 7987 | 4 |
7.860 | 11493 | 5 |
Last trade - 15.59pm 27/06/2025 (20 minute delay) ? |
Featured News
GNC (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online